Free Trial

What is Seaport Res Ptn's Estimate for Innospec Q3 Earnings?

Innospec logo with Basic Materials background

Key Points

  • Seaport Res Ptn has lowered its Q3 2025 earnings per share forecast for Innospec Inc. from $1.28 to $1.12, while maintaining a "Strong-Buy" rating.
  • Innospec recently reported earnings of $1.26 per share for its last quarter, beating expectations and showing a 1.1% year-over-year revenue increase.
  • Institutional investors hold 96.64% of Innospec's stock, with notable recent increases in stakes by companies like Principal Financial Group and Deutsche Bank.
  • Want stock alerts on Innospec? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Innospec Inc. (NASDAQ:IOSP - Free Report) - Stock analysts at Seaport Res Ptn reduced their Q3 2025 earnings per share (EPS) estimates for shares of Innospec in a report issued on Thursday, August 7th. Seaport Res Ptn analyst M. Harrison now forecasts that the specialty chemicals company will earn $1.12 per share for the quarter, down from their prior forecast of $1.28. Seaport Res Ptn has a "Strong-Buy" rating on the stock. The consensus estimate for Innospec's current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec's Q4 2025 earnings at $1.55 EPS, FY2025 earnings at $5.35 EPS, Q1 2026 earnings at $1.54 EPS, Q2 2026 earnings at $1.45 EPS and FY2026 earnings at $6.31 EPS.

Innospec (NASDAQ:IOSP - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.17 by $0.09. Innospec had a return on equity of 10.89% and a net margin of 1.08%. The firm had revenue of $439.70 million for the quarter, compared to analyst estimates of $440.70 million. During the same quarter in the previous year, the company posted $1.39 EPS. The business's revenue was up 1.1% on a year-over-year basis.

Separately, Wall Street Zen lowered Innospec from a "buy" rating to a "hold" rating in a research report on Tuesday, May 6th.

View Our Latest Stock Report on IOSP

Innospec Stock Up 2.0%

Shares of NASDAQ IOSP traded up $1.63 during trading on Friday, reaching $81.44. The company had a trading volume of 202,501 shares, compared to its average volume of 196,871. The company's fifty day moving average price is $84.64 and its 200-day moving average price is $92.53. Innospec has a 12 month low of $74.10 and a 12 month high of $128.35. The stock has a market cap of $2.02 billion, a P/E ratio of 104.41 and a beta of 1.07.

Insider Activity at Innospec

In related news, Director Leslie J. Parrette sold 446 shares of the company's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $90.63, for a total transaction of $40,420.98. Following the sale, the director owned 5,497 shares in the company, valued at $498,193.11. This represents a 7.50% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.31% of the company's stock.

Institutional Investors Weigh In On Innospec

Institutional investors and hedge funds have recently made changes to their positions in the business. BNP PARIBAS ASSET MANAGEMENT Holding S.A. bought a new stake in shares of Innospec during the 2nd quarter valued at about $28,000. Tsfg LLC bought a new stake in shares of Innospec during the 1st quarter valued at about $35,000. Blue Trust Inc. boosted its position in shares of Innospec by 38.3% during the 2nd quarter. Blue Trust Inc. now owns 672 shares of the specialty chemicals company's stock valued at $57,000 after purchasing an additional 186 shares in the last quarter. Covestor Ltd boosted its position in shares of Innospec by 13.9% during the 4th quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company's stock valued at $106,000 after purchasing an additional 118 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd bought a new stake in shares of Innospec during the 1st quarter valued at about $121,000. Institutional investors own 96.64% of the company's stock.

About Innospec

(Get Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Featured Stories

Earnings History and Estimates for Innospec (NASDAQ:IOSP)

Should You Invest $1,000 in Innospec Right Now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines